aboutUs_006
聯絡我們English繁體中文簡體中文
logo_isdlogo_isd

Microbio

MENUMENU
MENUMENU
  • Contact us
  • ABOUT US
    • ABOUT
    • CORE VALUE
    • COMPANY STRATEGY
    • ESTABLISHMENT HISTORY
    • CORPORATE LOGO
    • Management Team
    • GOVERNANCE STRUCTURE
  • Science And R&D
    • Technology platform
      • SYMBIOTA™
    • Clinical Pipeline
    • Nwe drug
      • MS-20
        • PRODUCT INFORMATION
        • CLINICAL EFFICACY
        • FAQ
        • CONTACT US
      • HERBIRON
    • MEDICAL DEVICES
      • MB-107
      • MB-828
    • Medical nutrition
      • MS-20
      • LT-17
      • MB-901
    • Publication
  • NEWS
  • INVESTORS
    • Corporate Governance
      • GOVERNANCE STRUCTURE
      • CORPORATE GOVERNANCE OFFICER
      • BOARD OF DIRECTORS
      • MAJOR INTERNAL POLICIES
      • COMPOSITION OF SHAREHOLDERS
    • Financials
      • MONTHLY REVENUE
      • FINANCIAL REPORTS
    • INVESTOR CONFERENCE
      • INVESTOR CONFERENCE
    • SHAREHOLDERS’ MEETING
      • SHAREHOLDERS’ MEETING
  • ESG
    • SUSTAINABLE MANAGEMENT
      • Message from the Chairman
      • Sustainability Goals and Vision
      • Sustainability Performance
      • Sustainable Management Structure
      • Engagement with Stakeholders and Material Topics Analysis
      • Response to SDGs
    • social inclusion
      • Industry-Academia Collaboration
      • Public Welfare and Donation
      • Actions for Access to Medicines
      • Public participation
      • Supporting Animal Welfare Issues
    • HEALTH CARE
      • Innovative Drugs Research and Development
      • Clinical Trials
      • Drug Safety
      • Supply Chain Management
      • Health Product R&D and Safety
      • Food Quality and Safety
      • Customer Relationship Management
      • Ethical Marketing
    • CORPORATE GOVERNANCE
      • Governance Practices
      • Integrity-Based Operation
      • Internal Audit
      • Risk Management
      • Regulatory Compliance
      • Cyber Security
      • Intellectual Property Rights Protection
    • SAFE WORKPLACE
      • Trustworthy Employer
      • Talent Development and Cultivation
      • Compensation and Benefits
      • Labor Rights
      • Healthy and Safe Working Environment
    • ENVIRONMENTAL PROTECTION
      • Climate Actions
      • Usage of Water Resources
      • Waste Management
      • PackagingMaterialsManagement
      • Environmental Management
      • Carbon Reduction Strategy
    • ESG DATABASE
      • ESG Report
      • Policy Statements and Management System Certificates
    • INTERACTION ZONE
    • STAKEHOLDER QUESTIONNAIRE
  • CAREERS
    • CHOOSE MICROBIO
    • COMPENSATION & BENEFITS
    • JOIN MICROBIO
    • LEARNING DEVELOPMENT
MENUMENU
MENUMENU
  • Contact us
  • ABOUT US
    • ABOUT
    • CORE VALUE
    • COMPANY STRATEGY
    • ESTABLISHMENT HISTORY
    • CORPORATE LOGO
    • Management Team
    • GOVERNANCE STRUCTURE
  • Science And R&D
    • Technology platform
      • SYMBIOTA™
    • Clinical Pipeline
    • Nwe drug
      • MS-20
        • PRODUCT INFORMATION
        • CLINICAL EFFICACY
        • FAQ
        • CONTACT US
      • HERBIRON
    • MEDICAL DEVICES
      • MB-107
      • MB-828
    • Medical nutrition
      • MS-20
      • LT-17
      • MB-901
    • Publication
  • NEWS
  • INVESTORS
    • Corporate Governance
      • GOVERNANCE STRUCTURE
      • CORPORATE GOVERNANCE OFFICER
      • BOARD OF DIRECTORS
      • MAJOR INTERNAL POLICIES
      • COMPOSITION OF SHAREHOLDERS
    • Financials
      • MONTHLY REVENUE
      • FINANCIAL REPORTS
    • INVESTOR CONFERENCE
      • INVESTOR CONFERENCE
    • SHAREHOLDERS’ MEETING
      • SHAREHOLDERS’ MEETING
  • ESG
    • SUSTAINABLE MANAGEMENT
      • Message from the Chairman
      • Sustainability Goals and Vision
      • Sustainability Performance
      • Sustainable Management Structure
      • Engagement with Stakeholders and Material Topics Analysis
      • Response to SDGs
    • social inclusion
      • Industry-Academia Collaboration
      • Public Welfare and Donation
      • Actions for Access to Medicines
      • Public participation
      • Supporting Animal Welfare Issues
    • HEALTH CARE
      • Innovative Drugs Research and Development
      • Clinical Trials
      • Drug Safety
      • Supply Chain Management
      • Health Product R&D and Safety
      • Food Quality and Safety
      • Customer Relationship Management
      • Ethical Marketing
    • CORPORATE GOVERNANCE
      • Governance Practices
      • Integrity-Based Operation
      • Internal Audit
      • Risk Management
      • Regulatory Compliance
      • Cyber Security
      • Intellectual Property Rights Protection
    • SAFE WORKPLACE
      • Trustworthy Employer
      • Talent Development and Cultivation
      • Compensation and Benefits
      • Labor Rights
      • Healthy and Safe Working Environment
    • ENVIRONMENTAL PROTECTION
      • Climate Actions
      • Usage of Water Resources
      • Waste Management
      • PackagingMaterialsManagement
      • Environmental Management
      • Carbon Reduction Strategy
    • ESG DATABASE
      • ESG Report
      • Policy Statements and Management System Certificates
    • INTERACTION ZONE
    • STAKEHOLDER QUESTIONNAIRE
  • CAREERS
    • CHOOSE MICROBIO
    • COMPENSATION & BENEFITS
    • JOIN MICROBIO
    • LEARNING DEVELOPMENT

May, 2024

Home2024May (Page 2)
news-3
News2024-05-23

Announcement major subsidiary Cotton Field Organic Co.,Ltd. of 2024 Shareholder’s Meeting to approve the release of non-compete restrictions for the directors.

Announcement major subsidiary Cotton Field Organic Co.,Ltd. of 2024 Shareholder’s Meeting to approve the release of non-compete restrictions for the directors.

33
Read More
news-3
News2024-05-17

Microbio Co., Ltd. receives a Australia patent on the new drug MS-20 (CHEMO YOUNG).

Microbio Co., Ltd. receives a Australia patent on the new drug MS-20 (CHEMO YOUNG).

33
Read More
news-3
News2024-05-17

Microbio Co., Ltd. receives a Japan patent on the new drug MS-20 (CHEMO YOUNG).

Microbio Co., Ltd. receives a Japan patent on the new drug MS-20 (CHEMO YOUNG).

35
Read More
news-3
News2024-05-14

Announcement of Year 2024Q1 consolidated financial reports were approved by the BOD

Announcement of Year 2024Q1 consolidated financial reports were approved by the BOD

38
Read More
news-3
News2024-05-12

Due to the change in FDA review requirements, Microbio has withdrawn 510(k) application of MB107 cream medical device.

Due to the change in FDA review requirements, Microbio has withdrawn 510(k) application of MB107 cream medical device.

34
Read More
news-3
News2024-05-08

Microbio and Oneness Ranked among Top 5% in the 10th Corporate Governance Evaluation

Microbio and Oneness Ranked among Top 5% in the 10th Corporate Governance Evaluation

37
Read More
news-3
News2024-05-03

Announcement of the Company’s Board meeting date for the First Quarter of 2024 Consolidated Financial Statements

Announcement of the Company’s Board meeting date for the First Quarter of 2024 Consolidated Financial Statements

38
Read More
1 2
Address:
18 F.-1, No. 3, Yuanqu St., Sanchong Vil., Nangang Dist., Taipei City, Taiwan
TEL: 02-2655-8558
FAX: 02-2655-8559

Longtan Factory Address:
No. 81, Gaoyang N. Road, Longtan District, Taoyuan City , Taiwan
  • Facebook
  • YouTube
版權所有 © 中天生物科技股份有限公司. All Rights Reserved.
Copyright © Microbio Co., Ltd. All Rights Reserved.
隱私權條款 | 使用者條款
privacy policy | Terms of service

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.